High expression of a novel splicing variant of VEGF, L-VEGF144 in glioblastoma multiforme is associated with a poorer prognosis in bevacizumab treatment.

Wen-Yu ChengChiung-Chyi ShenMing-Tsang ChiaoYea-Jiuan LiangTsuo-Fei MaoBai-Shuan LiuJun-Peng Chen

Published in: Journal of neuro-oncology (2018)

Taken together, these results indicated that the expression of L-VEGF144 could potentially serve as an independent indicator of poor prognosis in bevacizumab treatment.

Keyphrases

poor prognosis
long non coding rna
vascular endothelial growth factor
endothelial cells
metastatic colorectal cancer
smoking cessation